Enhancing the NHS-academia interface
The Academy of Medical Sciences has launched its report exploring how the interface between academia and the NHS can be enhanced to improve the health and wealth of the UK.
Status: Implementation
Read more
- You are here:
- Policy
- Overview
- All policy projects
234 records found
.
Building the evidence base on the impact of investing in UK research and innovation
The Government has committed to increasing research and development (R&D) spending to 2.4% of GDP within the next 10 years, with a long-term goal of 3%. In this context the National Academies have recognised the need to better understand the benefits that R&I bring to the UK and how those benefits are achieved.
Status:
Read more
Artificial intelligence and health
The Academy has held a number of events exploring the potential applications, and associated challenges of applying artificial intelligence approaches to research and healthcare.
Status: Ongoing
Read more
The Academy of Medical Sciences and The Lancet International Health Lecture 2018
Dr Irene Akua Agyepong delivered the 2018 Academy of Medical Sciences and The Lancet International Health Lecture under the title 'Universal Health Coverage: Global policy agenda breakthrough or great white elephant'?
Status: Completed
Read more
Bridging the preclinical-clinical boundary
The preclinical-clinical boundary is a key checkpoint in the translational pathway for research. It refers to the point at which preclinical evidence is considered sufficient to merit the move to first-in-human clinical studies, and represents a significant escalation in both resourcing and time, with a high risk of failure. Therefore there is a drive to ensure that the evidence base for progression into clinical studies is as robust and predictive as possible to maximise the chances of success and minimise risk of failure.
Status: Completed
Read more
Early detection and diagnosis research in cancer
One of the key ways to improve cancer outcomes is to detect and diagnose at an earlier stage when cancers are far more treatable. However, a limitation to the earlier diagnosis of some cancers is the lack of technologies that can detect very early indicators of disease. This means research into novel tests and innovations, and the rapid implementation of effective interventions into the healthcare system, are crucial.
Status: Completed
Read more
Improving the development and deployment of rapid diagnostic tests in South East Asia
The Academy of Medical Sciences, in collaboration with the Philippines National Academy of Science and Technology (NAST), convened a policy workshop on rapid diagnostic tests in South East Asia in Manila, Philippines on the 23-24 October 2018.
Status: Completed
Read more
Advancing research to tackle multimorbidity: the UK and LMIC perspectives
On 20 and 21 June 2018, the Academy hosted a two-day workshop on the topic of multimorbidity together with the MRC (now part of UKRI), the NIHR, and Wellcome.
Status: Completed
Read more
Science to transform maternal and newborn survival and stillbirths in sub-Saharan Africa in the SDG era
The Academy of Medical Sciences, in collaboration with the African Academy of Sciences, convened a policy workshop on maternal and newborn survival and stillbirths in sub-Saharan Africa in Nairobi, Kenya on the 4-5 September 2018.
Status: Completed
Read more
AMS response to the Next Generation Researchers Initiative
In response to a request from the US National Academy of Sciences, the Academy produced a paper providing a UK snapshot of efforts by the research community to aid the transition to independent research careers for biomedical researchers. The Academy's paper was published in May 2018.
Status:
Read more
Key contacts
Dr Rachel Quinn
Director of Medical Science Policy
Tel: 020 3141 3215
View staff bio